Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and
effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC
has developed a generic formulation of adapalene 0.3% topical gel and the current study is
designed to evaluate the safety and efficacy of this formulation.